Evaluating the Abuse Potential of NEURONTIN® When Taken Orally in Healthy Non-drug Dependent Participants With Sedative Drug Abuse Experience

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This will be a randomized, double-blind, double-dummy, placebo- and active controlled, 5 treatment, 10 sequence, 5 period crossover single dose, Williams square design study in healthy adult, non drug dependent male and female participants with drug abuse experience with sedative drugs.
Epistemonikos ID: 72ed7ef8ba0757b30cab3439fffa836aaa97782f
First added on: May 07, 2024